Analysis

The U.S. Food and Drug Administration has removed the clinical hold on Ocugen's promising ocular therapeutic candidate OCU200, clearing the...

The corporate transformation of Ikena Oncology into ImageneBio has reached a significant administrative milestone with the recent submission of regulatory...

Method Electronics finds itself in a precarious position, with its shares caught between conflicting market forces. Despite delivering a quarterly...

After an extended period of decline, Abeona Therapeutics is demonstrating renewed momentum. The biotechnology firm is gaining traction from a...

Specialty retailer Zumiez finds itself navigating turbulent waters as conflicting signals emerge about its financial health. While recent quarterly results...

The Swiss food conglomerate Nestlé has unexpectedly withdrawn from the Dairy Methane Action Alliance, a significant climate coalition focused on...

Investors in Idorsia received an unexpected jolt as the biotechnology firm unveiled plans for a substantial capital increase through an...

The biotechnology sector faces renewed scrutiny as Iovance Biotherapeutics experiences significant market pressure. Disappointing quarterly performance and emerging class action...

Marvell Technology, the specialized semiconductor firm, is currently undergoing a significant price adjustment following a remarkable rally that saw its...

The price of gold has achieved a historic first, surging past the $4,000 per ounce mark, and the world's largest...